7.95
전일 마감가:
$8.14
열려 있는:
$8.2
하루 거래량:
13,794
Relative Volume:
0.02
시가총액:
$10.54M
수익:
$1.47M
순이익/손실:
$-97.61M
주가수익비율:
-5.3356
EPS:
-1.49
순현금흐름:
$-80.90M
1주 성능:
+0.63%
1개월 성능:
-35.37%
6개월 성능:
-15.25%
1년 성능:
-48.54%
Lyra Therapeutics Inc Stock (LYRA) Company Profile
명칭
Lyra Therapeutics Inc
전화
617-373-4600
주소
480 ARSENAL WAY, WATERTOWN, MA
LYRA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
LYRA
Lyra Therapeutics Inc
|
7.95 | 13.01M | 1.47M | -97.61M | -80.90M | -1.49 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-05-07 | 다운그레이드 | BofA Securities | Buy → Underperform |
2024-05-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2024-05-07 | 다운그레이드 | Jefferies | Buy → Hold |
2024-05-06 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2023-10-06 | 재개 | BTIG Research | Buy |
2023-08-31 | 개시 | H.C. Wainwright | Buy |
2022-05-24 | 개시 | Cantor Fitzgerald | Overweight |
2020-05-26 | 개시 | BTIG Research | Buy |
2020-05-26 | 개시 | BofA/Merrill | Buy |
2020-05-26 | 개시 | Jefferies | Buy |
2020-05-26 | 개시 | William Blair | Outperform |
모두보기
Lyra Therapeutics Inc 주식(LYRA)의 최신 뉴스
How high can Lyra Therapeutics Inc. stock price go in 2025Free Bull & Bear Market Updates - jammulinksnews.com
What makes Lyra Therapeutics Inc. stock price move sharplyHigh Return Potential - Newser
Is Lyra Therapeutics Inc. a good long term investmentUnstoppable trading performance - Autocar Professional
Lyra Therapeutics Inc. Stock Analysis and ForecastRobust investment performance - Autocar Professional
What analysts say about Lyra Therapeutics Inc. stockRobust financial gains - Autocar Professional
What drives Lyra Therapeutics Inc. stock priceExponential wealth increase - jammulinksnews.com
Lyra Therapeutics (LYRA) Proposes Sale of 846,744 Shares of Comm - GuruFocus
How Lyra Therapeutics Inc. stock performs during market volatilityFree Predictions - Newser
Why Lyra Therapeutics Inc. stock attracts strong analyst attentionConsistent High Return Strategy - beatles.ru
Lyra Therapeutics CFO Cavalier sells $6k in shares By Investing.com - Investing.com Canada
Lyra Therapeutics CEO Palasis sells $13944 in stock By Investing.com - Investing.com Nigeria
Lyra Therapeutics CEO Palasis sells $13944 in stock - Investing.com
Lyra Therapeutics (NASDAQ:LYRA) Downgraded to Sell Rating by Wall Street Zen - Defense World
Lyra Therapeutics (NASDAQ:LYRA) Stock Rating Upgraded by Wall Street Zen - Defense World
Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - The Manila Times
Lyra Therapeutics Secures $4.3M in Direct Offering - TipRanks
Is Lyra Therapeutics, Inc. overvalued or undervalued? - MarketsMojo
Lyra Therapeutics regains Nasdaq compliance as stock maintains $1 minimum - Investing.com
Lyra Therapeutics: Regulatory Pathway For Non-Polyp Patients, An Underappreciated Catalyst - Seeking Alpha
Lyra Therapeutics, Inc. (NASDAQ:LYRA) Stake Lessened by Two Sigma Investments LP - Defense World
HC Wainwright Expects Higher Earnings for Lyra Therapeutics - Defense World
Lyra Therapeutics (LYRA) Upgraded to Buy: Here's Why - sharewise
Lyra Therapeutics Inc (LYRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lyra Therapeutics Inc 주식 (LYRA) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Cavalier Jason | Chief Financial Officer |
Jul 10 '25 |
Sale |
8.91 |
684 |
6,094 |
519,316 |
자본화:
|
볼륨(24시간):